Sanofi Pasteur, the vaccines division of Sanofi, on Tuesday said its affiliate Shantha Biotechnics has completed delivery of 20 million doses of Inactivated Polio Vaccine ShanIPV to the Indian government.
Laxma Reddy, Minister for Health, Medical and Family Welfare flagged off the final shipment from Shantha Biotechnics’ manufacturing site in Medchal, Telangana.
The company said in a statement that Polio is a highly infectious disease caused by a virus and one in 200 infections leads to irreversible paralysis (usually in the legs). Among those paralysed, 5 per cent to 10 per cent die when their breathing muscles become immobilised. There is no cure for polio- it can only be prevented by vaccination.
Jean-Pierre Baylet, country head, Sanofi Pasteur (South Asia), said, “Since 2015, after one of the most extensive public health campaign in history, Sanofi Pasteur is supporting the Government’s efforts to keep India polio-free with millions of doses of ShanIPV and Imovax Polio. Today, every second baby in India is being vaccinated with one of the two Sanofi Pasteur’s Inactivated Polio Vaccines (IPV).”
Dr. Shailesh Ayyangar, MD-India and Head – South Asia, Sanofi, said, “The most significant impact that Sanofi has made on healthcare in India is by supporting the Government’s efforts to eradicate polio. Sanofi Pasteur, through its affiliate, Shantha Biotechnics, was the first company to partner with the Indian Government, directly and via the UNICEF, in supplying IPV to achieve the goal of a polio-free world.”